UK markets closed

BioSenic S.A. (0R55.L)

LSE - LSE Delayed price. Currency in EUR
Add to watchlist
0.1020+0.0100 (+10.87%)
At close: 04:29PM BST
Full screen
Previous close0.0920
Open0.0900
Bid0.0000 x N/A
Ask0.0000 x N/A
Day's range0.0850 - 0.1295
52-week range0.0250 - 0.3455
Volume355,137
Avg. volume40,871
Market cap10,425
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)-0.7670
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Globe Newswire

    BioSenic publishes new evidence of beneficial effects of arsenic trioxide treatment supporting clinical trial for systemic sclerosis

    INSIDE INFORMATIONS BioSenic publishes new evidence of beneficial effects of arsenic trioxide treatment supporting clinical trial for systemic sclerosis Arsenic trioxide (ATO) therapeutic potential to treat systemic sclerosis (SSc) is now confirmed in a new preclinical model - Fra2- characterized by severe pulmonary lesions Mont-Saint-Guibert, Belgium, September 19, 2023, 7.00 am CEST – BIOSENIC (Euronext Brussels and Paris: BIOS), the clinical-stage company specializing in serious autoimmune an

  • Globe Newswire

    BioSenic reaches agreement on binding term sheets with main creditors to restructure past financial debts

    INSIDE INFORMATION New binding term sheets have been formulated upon for the replacement of the Monument and Patronale bonds and loans by new unsecured convertible bonds as well as for the long-term extension of the past loan financing with the European Investment Bank. Mont-Saint-Guibert, Belgium, September 14, 2023, 7.00 am CEST – BIOSENIC (Euronext Brussels and Paris: BIOS), the clinical-stage company specializing in serious autoimmune and inflammatory diseases and cell therapy, today announc

  • Globe Newswire

    BioSenic reports half year 2023 results

    REGULATED INFORMATION The interim financial report is prepared in accordance with article 13 of the Royal Decree on the obligations of issuers of financial instruments admitted to trading on a regulated market and can be accessed on the website of Biosenic in the section ‘Financial reports’. BioSenic publishes its interim financial report in English. A French translation of the report will also be made available. In the event of differences between the English and the French version of the repor